Abstract
Transdermal drug delivery is an attractive non-invasive method offering numerous advantages over the conventional routes of administration. The main obstacle to drug transport is, however, the powerful skin barrier that needs to be modulated, for example, by transdermal permeation enhancers. Unfortunately, there are still only a few enhancers showing optimum properties including low toxicity and reversibility of enhancing effects. For this reason, we investigated a series of new N-alkylmorpholines with various side chains as potential enhancers in an in vitro permeation study, using three model permeants (theophylline, indomethacin, diclofenac). Moreover, electrical impedance, transepidermal water loss, cellular toxicity and infrared spectroscopy measurements were applied to assess the effect of enhancers on skin integrity, reversibility, toxicity and enhancers’ mode of action, respectively. Our results showed a bell-shaped relationship between the enhancing activity and the hydrocarbon chain length of the N-alkylmorpholines, with the most efficient derivatives having 10–14 carbons for both transdermal and dermal delivery. These structures were even more potent than the unsaturated oleyl derivative. The best results were obtained for indomethacin, where particularly the C10-14 derivatives showed significantly stronger effects than the traditional enhancer Azone. Further experiments revealed reversibility in the enhancing effect, acceptable toxicity and a mode of action based predominantly on interactions with stratum corneum lipids.
Highlights
The transdermal application of drugs is an important administration route, providing many benefits, such as the avoidance of the first-pass metabolism, controlled drug delivery over long time periods, and increased patient compliance
We studied seven new morpholine derivatives with various side-chain lengths as potential skin permeation enhancers
DF, were larger molecules with higher lipophilicity than that of TH, but they differed in their solubility in the donor phase
Summary
The transdermal application of drugs is an important administration route, providing many benefits, such as the avoidance of the first-pass metabolism, controlled drug delivery over long time periods, and increased patient compliance. The main aim of the transdermal formulation is an adequate drug permeation rate through the skin to the bloodstream [1,2]. In dermal delivery, the major target is the skin tissue where sufficient drug concentrations are needed. For both transdermal and dermal deliveries, the skin protective function hinders the entrance of external substances into the organism and represents a fundamental obstacle. The main skin barrier is located in its uppermost layer, the stratum corneum (SC) [3,4]. The “mortar” is the lipid matrix of characteristic composition (ceramides, cholesterol and free fatty acids of various lengths) [5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
